SGC2085 is primarily utilized in the field of medical research, particularly in the study and treatment of various cancers. It functions as a potent inhibitor of specific enzymes that are often overactive in cancer cells, thereby helping to slow down or halt the progression of the disease. Researchers are investigating its efficacy in targeting and disrupting the pathways that cancer cells use to grow and survive, making it a promising candidate for developing new anticancer therapies. Additionally, SGC2085 is being explored for its potential in combination with other treatments to enhance overall therapeutic outcomes. Its role in preclinical studies is crucial for understanding the mechanisms of cancer and for paving the way for future clinical applications.